Lantheus Holdings Inc. stock reached a new 52-week high, closing at $101.01. The current price of $98.28 remains near that peak.
This milestone reflects strong performance over the past year, with the stock appreciating 27.74%. The momentum has been even more impressive recently: a 42% year-to-date gain and a 69% surge over the past six months.
Analysts have revised earnings upwards for the upcoming period. Bond.az's Financial Health Score rates the company as "GREAT."
Lantheus Holdings, known for medical diagnostic products, continues to attract attention with robust stock performance. The 52-week high highlights the company's resilience and growth potential.
In other news, Lantheus Holdings reported impressive Q1 2026 results, surpassing expectations. Adjusted EPS was $1.46 versus the forecast $1.23. Revenue of $377.3 million exceeded the anticipated $354.87 million.
This article was generated with AI support and reviewed by an editor. For more information, see our T&C.
